introduction to clinical protocol
DESCRIPTION
Introduction to Clinical Protocol. Topics To be Covered. What is Protocol Protocol Outline Protocol Design Study Procedure Informed Consent process Subject Confidentially Data Recording GCDMP Data Management Plan Data Capture. Data Quality Assurance Data Validation - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/1.jpg)
Qtech Solutions Inc., NJ USA 1
Introduction to Clinical Protocol
![Page 2: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/2.jpg)
Topics To be Covered What is Protocol Protocol Outline Protocol Design Study Procedure Informed Consent process Subject Confidentially Data Recording GCDMP Data Management Plan Data Capture
Data Quality Assurance Data Validation Query Management Plan Best Practice for CRF Statistical Analysis Data Locking Appendices / Supplements Conclusion
Qtech Solutions Inc., NJ USA 2
![Page 3: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/3.jpg)
Protocol• A protocol is a document that states the reasoning
behind and structure of a research project
• Protocol also defined as a document that describes the background, rationale, objectives, design, methodology, statistical consideration and organization of trial
• The Study protocol can be viewed as a written agreement between the investigator , the participants and the scientific community
Qtech Solutions Inc., NJ USA 3
![Page 4: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/4.jpg)
Protocol OutlineA typical protocol has the following elements:
• Title Page• Objectives• Signature Page• Study Design• Background Information and scientific rationale• Study Population
Qtech Solutions Inc., NJ USA 4
![Page 5: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/5.jpg)
Protocol Design
• Study Procedure• Informed Consent process• Statistical Considerations• Literature References• Subject Confidentiality• Supplements / Appendices
Qtech Solutions Inc., NJ USA 5
![Page 6: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/6.jpg)
Title Page1. Title pages introduce the document, their title,
precise number, sponsor and author to the reader• Protocol title, protocol identifying number, and
date• Any amendments should also bear the amendment
number and date• The protocol number must clearly indicate the
version number, whether it is final or draft and date of this version
Qtech Solutions Inc., NJ USA 6
![Page 7: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/7.jpg)
Continue…Elements
Full title should include:
1. Summary study design
2. Medicinal products3. Nature of the
treatment (ex: treatment, prophylaxis and diagnosis)
4. Comparator
5. Placebo6. Indication 7. Patient population8. Setting (ex: in-
patient, outpatient)9. Randomized 10. Double Blind11. Multiple Studies
Qtech Solutions Inc., NJ USA 7
![Page 8: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/8.jpg)
Continue…
2. Name and address of the sponsor and monitor. Sponsor names and list of responsibilities with agreed allocations
3. Name and title of the person authorized to sign the protocol and the protocol amendments for the sponsor. Generally, Chief Investigator for multiple center trials or Principal Investigator for single center trials
4. Name, title, address and telephone number of the sponsor medical expert for the trial
Qtech Solutions Inc., NJ USA 8
![Page 9: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/9.jpg)
Continue…5. Name and title of the investigator who is responsible for
conducting the trial, and the address and telephone numbers of the trial site
6. Name, title , address and telephone number of the qualified physician who is responsible for all trial site related medical decisions
7. Name and address of the clinical laboratory and other medical and /or technical department and /or institution involved in the trial
Qtech Solutions Inc., NJ USA 9
![Page 10: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/10.jpg)
Protocol Summary/Synopsis
• This summary should be only one to two pages long
• It should give the reader sufficient information to understand the rationale for the trial, its objective and the methods that will be used to achieve these objectives
Qtech Solutions Inc., NJ USA 10
![Page 11: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/11.jpg)
Study Objective/Aims• A clinical trial often has both primary and
secondary objective, and these should be identified as such in the protocol
• Ideally, no more than 1 or 2 of each should be included in a clinical trial
Qtech Solutions Inc., NJ USA 11
![Page 12: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/12.jpg)
Signature Page• Signature page of the healthcare professional in the
trial including contact details of participating site, sponsor and sponsor medical advisor if not already given above.
Qtech Solutions Inc., NJ USA 12
![Page 13: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/13.jpg)
Content Page
• This helps navigating through the document by large number of different people that will be needed throughout the life of the trial
Qtech Solutions Inc., NJ USA 13
![Page 14: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/14.jpg)
Study DesignA description of the trial design should include:
1) A description of the design of trial to be conducted ex: double blind, placebo controlled, parallel design
2) A description of the measure taken to minimize/ avoid bias
A) RandomizationB) Blinding
Qtech Solutions Inc., NJ USA 14
![Page 15: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/15.jpg)
Continue…
3) A description of the trial treatment and the dosage and dosage regimen of the IP. Also, include a description of the dosage form, packaging and labeling of the IP
4) The expected duration of subject participation , and description of the sequence and duration of all trial periods, including follow up any.
5) A description of “stopping rile” or “Discontinuation Criteria”
Qtech Solutions Inc., NJ USA 15
![Page 16: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/16.jpg)
List of Abbreviation• All abbreviations used should be listed and defined
• Accepted international medical abbreviations should be used
• Project specific abbreviations should be standardized with each project
Qtech Solutions Inc., NJ USA 16
![Page 17: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/17.jpg)
Compliance Statement
• The protocol should include a trial statement with the protocol, GCP and the applicable regulatory requirements
Qtech Solutions Inc., NJ USA 17
![Page 18: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/18.jpg)
Background Information• Name and description of the investigational product
• A summary of finding from nonclinical studies that potentially have clinical significance and form clinical trials that are relevant to the trial
• Summary of the known and potential risks and benefits, if any, to human subjects
• Description and justification for the route of administration, dosage, dosage regimen and treatment period
Qtech Solutions Inc., NJ USA 18
![Page 19: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/19.jpg)
Continue…
• Description of the population to be studied
• In short, the data in this background information should be able to justify the need for this study
Qtech Solutions Inc., NJ USA 19
![Page 20: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/20.jpg)
Selection and Withdrawal of Subjects1. Subject Inclusion Criteria
2. Subject Exclusion Criteria
3. Subject Withdrawal Criteria
Qtech Solutions Inc., NJ USA 20
![Page 21: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/21.jpg)
Treatment of Subjectsi) The treatment to be administered, including the
name of all the products, dose, the dosing schedule, the route/mode of administration and the treatment period
ii) Medication/ treatment permitted and not permitted before and/ or during the trial.
iii) Procedure for monitoring subject compliance
Qtech Solutions Inc., NJ USA 21
![Page 22: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/22.jpg)
Assessment of Safetyi) Specification of safety parameters
ii) The methods and timing for assessing, recording, and analyzing safety parameters
iii) Procedure for eliciting reports of and recording and reporting adverse event and inter current illnesses
Qtech Solutions Inc., NJ USA 22
![Page 23: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/23.jpg)
Direct Access to Source Data Document
• Sponsor ensures that it is specified in the protocol or other written agreement that the investigator will permit trial related monitoring, audits, IEC review, and regulatory inspection by providing direct access to source data/documents
Qtech Solutions Inc., NJ USA 23
![Page 24: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/24.jpg)
Informed Consent• Defined as: a patient is being given adequate
information about a clinical trial; understanding and voluntarily accepting the terms of a clinical trials and agreeing to cooperate in its conduct
Qtech Solutions Inc., NJ USA 24
![Page 25: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/25.jpg)
The following slides are the key concepts to be considered while designing the protocol, which impact the Clinical Data Management
1. Data Recording2. Data Quality Assurance3. Statistical Analysis Plan
Qtech Solutions Inc., NJ USA 25
![Page 26: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/26.jpg)
Data Handling and Record Keeping
• Indicate how data will be collected. If detailed instructions have been prepared, specify their location (study manual, appendix)
• Discuss the use and management of source documents• Discuss the procedure for correcting errors
1. GCDMP2. Data Management Plan3. Data Capture4. CRF
Qtech Solutions Inc., NJ USA 26
![Page 27: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/27.jpg)
1. Good Clinical Data Management Practices◦ Provides assistance to clinical data managers in their
implementation of high quality Clinical Data Management processes
◦ Used as a reference tool for clinical data managers◦ Review and approval of new medications or medical
devices◦ Clinical and laboratory information must be collected and
converted to digital form for analysis and reporting purposes
Qtech Solutions, Inc., NJ, USA 27
Data Handling and Record Keeping
![Page 28: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/28.jpg)
2. Data Management Plan◦ Record all the most important information on how data
management was carried out for a study◦ The documents are more accurate when written at the start
of the study◦ Provides a focus for identifying the work to be performed,
who will perform the work, and what is to be produced as documentation of the work
Qtech Solutions, Inc., NJ, USA 28
Data Handling and Record Keeping
![Page 29: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/29.jpg)
2. Data Management PlanContinued…
◦ Touches the elements of the data management process for the study in question
◦ Becomes an approximate table of contents◦ Used as a source document for internal quality assurance
audits
Qtech Solutions, Inc., NJ, USA 29
Data Handling and Record Keeping
![Page 30: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/30.jpg)
3. Data Capture
Electronic Data Capture◦ EDC systems deliver clinical trial data from the investigation sites to the
sponsor◦ Eliminates the need for double-key data entry◦ Data management planning and implementation are completed even
before data entry is initiated EDC systems are improved for site activities during a
clinical trial
Qtech Solutions, Inc., NJ, USA 30
Data Handling and Record Keeping
![Page 31: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/31.jpg)
4. Best Practice for CRF A tool used to collect pre- defined data from a subject in a
clinical trial◦ Design the CRF along with protocol◦ Keep questions, prompts and instructions clear and concise◦ Design the CRF to follow the data flow from the perspective of the
person completing it◦ Avoid referential and redundant data points within the CRF◦ Design the CRF with the primary safety and efficacy endpoints in mind◦ Establish and maintain a library of standard forms◦ Make the CRF available for review at the clinical site prior to approval
Qtech Solutions, Inc., NJ, USA 31
Data Handling and Record Keeping
![Page 32: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/32.jpg)
Describe procedures for assessing subject compliance Discuss source document review• Provide assurance on good clinical practice, quality of data
collection and refer to monitor and their role
1. Data Validation2. Query Management
Data Quality Assurance
Qtech Solutions Inc., NJ USA 32
![Page 33: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/33.jpg)
1. Data Validation Important role within the drug development program
involving many people, multiple systems, and several data transfers
Automated and manual procedures to detect missing entries, illogical data
Ensures Data accuracy and Completeness Helps to inform Data Managers about data issues in timely
fashion Once data validation is completed it is time for Data
Treatment stage
Qtech Solutions, Inc., NJ, USA 33
Data Quality Assurance
![Page 34: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/34.jpg)
1. Data ValidationContinued…
Factors affecting the quality of data1. CRF design2. Field Monitoring Guidelines3. Source data verification4. Missing data/ CRF pages5. Data conventions6. Electronic laboratory data
Qtech Solutions, Inc., NJ, USA 34
Data Quality Assurance
![Page 35: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/35.jpg)
2. Query Management Performance metrics are tracked routinely and analyzed
periodically to ensure maintenance of the highest data management quality standards
All discrepancies are identified automatically by the system that are reviewed by a data manager
These are resolved internally through inspection of the CRF
Qtech Solutions, Inc., NJ, USA 35
Data Quality Assurance
![Page 36: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/36.jpg)
2. Query ManagementContinued…
Following actions can be taken based on project specific guidelines◦ Closing discrepancy per internal connection◦ Generating a query to the investigator
Creating queries Sending queries Tracking queries Resolving queries Re-quering
Qtech Solutions, Inc., NJ, USA 36
Data Quality Assurance
![Page 37: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/37.jpg)
2. Query ManagementContinued…
Turning a discrepancy into a query Resolving queries Applying the Resolution Quality assurance and control
Qtech Solutions, Inc., NJ, USA 37
Data Quality Assurance
![Page 38: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/38.jpg)
It is critical to specify in the protocol the precise definition of the primary variable as it will be used in the statistical analysis.
Oversees the processes that group, summarize, analyze, and otherwise present trial data for clinical interpretation
Statement of the planned sample size Classification of the study variables Information about the timing and purpose of any planned interim
analysis Handling of missing or non- evaluable data
Qtech Solutions, Inc., NJ, USA 38
Statistical Analysis Plan
![Page 39: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/39.jpg)
1. Data Locking Once the patient’s data has been collected, the study needs to
be locked in an expeditious manner The list involves many steps:
◦ Collecting final data ◦ Resolving outstanding queries◦ Reconciling against other databases◦ Performing final QC
After these tasks are done, data manager reviews with the clinical group and the study is considered locked- no data will be changed, from the first patient in through to database lock
Qtech Solutions, Inc., NJ, USA 39
Statistical Analysis Plan
![Page 40: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/40.jpg)
AppendicesBased on the protocol, relevant appendices as elaborated should be attached:
• Summary of Product characteristics, data sheer for IP
• Measurement tools and their validation
• Pharmacy information, shelf lives, dispensing procedure
• Methods for collecting patient samples, their storage, dispatch and handling conditions
Qtech Solutions Inc., NJ USA 40
![Page 41: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/41.jpg)
Continue…
• Clinical labs and tests• Adverse reaction grading systems for particular
safety parameters• Scoring systems of efficiency parameters• Analysis diagram• Declaration of Helsinki• Patients and parent/legal guardian consent form• Subject information sheet for informed consent• Method of recruitment of patients/subjects to the
trial
Qtech Solutions Inc., NJ USA 41
![Page 42: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/42.jpg)
Qtech Solutions Inc., NJ USA 42
Conclusion• Protocol is a blue print for a study. It contains all the information
necessary• Certain Information is required by regulation to be into protocol• The following are the key points that follow Data Management
Protocol:1. Data Recording
• GCDMP• DMP• Data Capture• CRF Practices
2. Quality Assurance• Data Validation• Query Management
3. Statistical Analysis• Data Locking
![Page 43: Introduction to Clinical Protocol](https://reader034.vdocuments.mx/reader034/viewer/2022050714/568165c4550346895dd8cffd/html5/thumbnails/43.jpg)
Qtech Solutions, Inc., NJ, USA 43
Thank YouFor queries or questions, please email at [email protected]